Naoki Nakamura

Establishment of phosphatidylinositol 3‐kinase inhibitor‐resistant cancer cell lines and therapeutic strategies for overcoming the resistance

T. Irimura, S. Dan, T. Yamori, 2012, Cancer science.

Incidence of and risk factors for non-hematologic toxicity with combined radiotherapy and CDK4/6 inhibitors in metastatic breast cancer using dose-volume parameters analysis: a multicenter cohort study

N. Araki, T. Kosugi, S. Sekii, 2022, Breast Cancer.

Basal expression of insulin-like growth factor 1 receptor determines intrinsic resistance of cancer cells to a phosphatidylinositol 3-kinase inhibitor ZSTK474

S. Dan, T. Yamori, Y. Nishimura, 2015, Cancer science.